[1]
2022. Assessment of Serum Podocalyxin as a Biomarker for Diabetic Nephropathy in Type 2 Diabetes patients in Duhok City. Journal of Life and Bio Sciences Research . 3, 02 (Nov. 2022), 71–75. DOI:https://doi.org/10.38094/jlbsr30275.